Related Experiment Video
Updated: Jan 28, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Secondary KIT mutations: the GIST of drug resistance and sensitivity
Andrea Napolitano1, Bruno Vincenzi2
1Università Campus Bio-Medico, Rome, Italy.
Abstract:
Pharmacological targeting of KIT in gastrointestinal stromal tumours has dramatically changed the clinical outcome of this disease. Tyrosine kinase inhibitors are the cornerstone of this improvement, but resistance occurs through secondary KIT mutations. Studies aimed at improving our understanding of the molecular basis of sensitivity and resistance will soon allow us to further tailor our therapeutic strategies.
Insights
Targeting KIT with tyrosine kinase inhibitors has improved outcomes for gastrointestinal stromal tumors. Understanding KIT mutations causing resistance will enable personalized therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Gastrointestinal stromal tumors (GIST) treatment has been revolutionized by targeting the KIT tyrosine kinase.
- Tyrosine kinase inhibitors (TKIs) are the primary treatment modality for GIST, significantly improving patient outcomes.
Discussion:
- Acquired resistance to TKIs in GIST often arises from secondary mutations in the KIT proto-oncogene.
- Understanding the molecular mechanisms underlying KIT-dependent signaling and TKI resistance is crucial for advancing GIST therapy.
Key Insights:
- KIT-targeted therapies offer a significant clinical benefit in GIST management.
- Secondary KIT mutations are a major cause of treatment failure and disease progression in GIST patients.
Outlook:
- Further research into the molecular basis of KIT sensitivity and resistance will facilitate the development of next-generation therapies.
- Personalized therapeutic strategies tailored to specific KIT mutation profiles hold promise for overcoming TKI resistance in GIST.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Viral Mutations
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Secondary Active Transport
Secondary Healthcare System
Primary and Secondary Growth in Roots and Shoots